Evaxion Biotech AS (EVAX)
1.68
-0.08
(-4.55%)
USD |
NASDAQ |
Nov 14, 16:00
1.73
+0.05
(+2.98%)
After-Hours: 20:00
Evaxion Biotech Cash and Short Term Investments (Quarterly): 4.576M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.576M |
| June 30, 2024 | 7.993M |
| March 31, 2024 | 11.73M |
| December 31, 2023 | 5.583M |
| September 30, 2023 | 2.605M |
| June 30, 2023 | 7.118M |
| March 31, 2023 | 10.24M |
| December 31, 2022 | 13.18M |
| September 30, 2022 | 17.85M |
| Date | Value |
|---|---|
| June 30, 2022 | 25.25M |
| March 31, 2022 | 31.41M |
| December 31, 2021 | 32.17M |
| September 30, 2021 | 11.94M |
| June 30, 2021 | 18.80M |
| March 31, 2021 | 26.96M |
| December 31, 2020 | 5.834M |
| September 30, 2020 | 7.876M |
| December 31, 2019 | 9.559M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.605M
Minimum
Sep 2023
32.17M
Maximum
Dec 2021
13.93M
Average
10.99M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Ascendis Pharma AS | 277.30M |
| Adaptimmune Therapeutics PLC | 214.79M |
| Akari Therapeutics PLC | 4.177M |
| Biodexa Pharmaceuticals PLC | 6.394M |
| Verona Pharma PLC | 336.04M |